SCHEMBL7149769

SCHEMBL7149769

COc1ccc(NC(=O)c2ccccc2)c(C(Nc2ccc(C(=N)NO)cc2)C(=O)NCc2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F2 P00734 4/20 0.46
PRSS1 P07477 4/20 0.46
F7 P08709 4/20 0.46
F10 P00742 3/20 0.46
HDAC1 Q13547 3/20 0.43
HDAC6 Q9UBN7 2/20 0.43
SCD O00767 1/20 0.42
MTTP P55157 1/20 0.41
PPARD Q03181 1/20 0.41
NPC1 O15118 4/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX12 P18054 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7149276 0.91 F2 (0.56) F2PRSS1F7F10HDAC1
Acetic Acid SCHEMBL8128379 0.89 F2 (0.55) F2PRSS1F7F10HDAC1
SCHEMBL7147520 0.89 F2 (0.53) F2PRSS1F7F10HDAC1
SCHEMBL7149712 0.86 F2 (0.50) F2PRSS1F7F10HDAC6
SCHEMBL7149300 0.86 F2 (0.50) F2PRSS1F7F10HDAC6
SCHEMBL7143873 0.85 F2 (0.60) F2PRSS1F7F10HDAC1
SCHEMBL7148118 0.83 F2 (0.51) F2PRSS1F7F10HDAC1
SCHEMBL8127685 0.82 F2 (0.54) F2PRSS1F7F10HDAC1
SCHEMBL7148395 0.81 F7 (0.56) F2PRSS1F7F10HDAC1
SCHEMBL7148405 0.81 F7 (0.56) F2PRSS1F7F10HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0921116-B1 N-(4-carbamimido-phenyl)-glycine amide derivatives HOFFMANN LA ROCHE (CH) 2003-06-18 EP disclosed
US-6140353-A USED AS MEDICAMENTS FOR THE TREATMENT AND/OR PREVENTION OF THROMBOSES, APOPLEXY, CARDIAC INFARCTION, INFLAMMATION AND ARTERIOSCLEROSIS OR AS ANTITUMOR AGENTS HOFFMANN-LA ROCHE INC. (US) 2000-10-31 US disclosed
EP-0921116-A1 N-(4-carbamimido-phenyl)-glycine amide derivatives F. HOFFMANN-LA ROCHE AG (CH) 1999-06-09 EP disclosed